Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies
- 31 December 1991
- journal article
- Published by Elsevier in Research in Immunology
- Vol. 142 (9) , 749-763
- https://doi.org/10.1016/0923-2494(91)90121-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATIONTransplantation, 1990
- SUCCESSFUL RETREATMENT OF ALLOGRAFT REJECTION WITH OKT3Transplantation, 1989
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate.The Journal of Experimental Medicine, 1985
- A hapten-specific chimaeric IgE antibody with human physiological effector functionNature, 1985
- Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores.The Journal of Experimental Medicine, 1985
- Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibodyEuropean Journal of Immunology, 1985
- Recombination events near the immunoglobulin C.mu. gene join variable and constant region genes, switch heavy-chain expression, or inactivate the locusBiochemistry, 1981